Skip to main content

Sertaconazole topical Pregnancy and Breastfeeding Warnings

Medically reviewed by Last updated on May 1, 2023.

Sertaconazole topical is also known as: Ertaczo

Sertaconazole topical Pregnancy Warnings

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus.

US FDA pregnancy category: C

Animal studies have failed to reveal evidence of embryotoxicity or teratogenicity with oral sertaconazole; increased stillbirths and reduction in live birth indices were reported in rats given oral doses of 20 to 40 times the maximum recommended human dose. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Sertaconazole topical Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

-The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Ertaczo (sertaconazole topical)." Bertek Pharmaceuticals Inc (2003):

References for breastfeeding information

  1. "Product Information. Ertaczo (sertaconazole topical)." Bertek Pharmaceuticals Inc (2003):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.